UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (5), p.1212-1226

2017

Volltextzugriff (PDF)

The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (3), p.873-883

2014

Volltextzugriff (PDF)

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

Autophagy, 2015-10, Vol.11 (10), p.1891-1904

2015

Volltextzugriff (PDF)

Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14), p.4068-4080

2016

Volltextzugriff (PDF)

Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor‐induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression

Molecular carcinogenesis, 2017-01, Vol.56 (1), p.18-35

2017

Volltextzugriff (PDF)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

British journal of cancer, 2017-09, Vol.117 (7), p.947-953

2017

Volltextzugriff (PDF)

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma

Journal of experimental & clinical cancer research, 2021-01, Vol.40 (1), p.33-33, Article 33

2021

Volltextzugriff (PDF)

Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells

American Journal of Physiology: Cell Physiology, 2011-09, Vol.301 (3), p.C609-C618

2011

Volltextzugriff (PDF)

Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas

Cells (Basel, Switzerland), 2021-05, Vol.10 (5), p.1222

2021

Volltextzugriff (PDF)

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

Theranostics, 2019-01, Vol.9 (18), p.5332-5346

2019

Volltextzugriff (PDF)

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma

PloS one, 2014-03, Vol.9 (3), p.e89449-e89449

2014

Volltextzugriff (PDF)

NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model

Cancer letters, 2018-02, Vol.414, p.88-98

2018

Volltextzugriff (PDF)

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor

Theranostics, 2020, Vol.10 (3), p.1107-1121

2020

Volltextzugriff (PDF)

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies

Oncotarget, 2017-02, Vol.8 (6), p.9174-9188

2017

Volltextzugriff (PDF)

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma

Cancers, 2022-01, Vol.14 (1), p.70

2022

Volltextzugriff (PDF)

Poly(A)-binding Protein-interacting Protein 2, a Strong Regulator of Vascular Endothelial Growth Factor mRNA

The Journal of biological chemistry, 2004-08, Vol.279 (33), p.34217-34226

2004

Volltextzugriff (PDF)

Measurement of Hemoglobin

Bio-protocol, 2012-11, Vol.2 (22)

2012

Volltextzugriff (PDF)

Measurement of Cytokines

Bio-protocol, 2012-11, Vol.2 (22)

2012

Volltextzugriff (PDF)

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Theranostics, 2019-01, Vol.9 (3), p.661-675

2019

Volltextzugriff (PDF)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-8

2010

Volltextzugriff (PDF)

Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs

RNA (Cambridge), 2006-06, Vol.12 (6), p.1074-1083

2006

Volltextzugriff (PDF)

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer

Cancer research (Chicago, Ill.), 2016-11, Vol.76 (22), p.6507-6519

2016

Volltextzugriff (PDF)

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

Theranostics, 2019-01, Vol.9 (18), p.5332-5346

2019

Volltextzugriff (PDF)

The ELR+CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma

Oncoimmunology, 2014, Vol.3 (4), p.e28399-e28399

2014

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(34)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(19)
Angiogenesis
(15)
Life Sciences
(14)
Animals
(13)
Cell Line, Tumor
(11)
Mice
(11)
Oncology
(11)
Female
(10)
Cancer
(9)
Carcinoma, Renal Cell - Pathology
(8)
Kinases
(8)
Metastasis
(8)
Tumors
(8)
Carcinoma, Renal Cell - Drug Therapy
(7)
Kidney Cancer
(7)
Angiogenesis Inhibitors - Pharmacology
(6)
Kidney Neoplasms - Pathology
(6)
Sunitinib
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas

The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins

Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor‐induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma

Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells

Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma

NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma

Poly(A)-binding Protein-interacting Protein 2, a Strong Regulator of Vascular Endothelial Growth Factor mRNA

Measurement of Hemoglobin

Measurement of Cytokines

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies

Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

The ELR+CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma

Suchergebnisse filtern